The Board is remanding the TDIU claim to the RO via the Appeals Management Center (AMC) in Washington, DC. The veteran's non-Hodgkin's lymphoma is currently rated at 10 percent and has been in remission since August 2004. There are no confirmed residuals of the disease. The Board finds that the preponderance of evidence does not support a higher rating for the non-Hodgkin's lymphoma.
The deciding factor: The veteran's non-Hodgkin's lymphoma is currently rated at 10 percent and has been in remission since August 2004. There are no confirmed residuals of the disease, and his hemoglobin levels do not meet the criteria for a higher rating under Diagnostic Code 7100.
- Claimed conditions
- Non-Hodgkin's Lymphoma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- November 1, 2007
- Citation
- 0734352
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 0734352.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran's service connection for leukemia, characterized as CLL, was improperly severed. Service connection for T-cell LGL leukemia is restored. The severance of service connection for NHL is upheld.
- Whole decision: Granted
The Board has restored a 100 percent rating for the Veteran's non-Hodgkin's lymphoma, effective April 1, 2025.
- Whole decision: Granted
The Veteran's SMC was granted at the intermediate level between 38 U.S.C. § 1114(m) and (n) due to additional disabilities including peripheral neuropathies, tinnitus, hearing loss, and lymphoma.
- Whole decision: Granted
The Veteran's non-Hodgkin's Lymphoma was granted a 100% rating effective February 8, 2019.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.